Both in Pharmaceuticals
DiaMedica Therapeutics vs Neurogene
Over the past year DMAC returned +47.1% and NGNE returned −14.1%; their daily moves had a correlation of 0.26.
DMAC +47.1% NGNE −14.1%Growth of $1, one year, split-adjusted
| Metric | DMAC | NGNE |
|---|---|---|
| Price | $10.00 | $26.67 |
| Market cap | $539.3M | $533.7M |
| Today | +7.64% | +0.23% |
| 1 month | +18.8% | +0.8% |
| 6 months | +60.0% | −7.8% |
| Year to date | +25.6% | +29.5% |
| 1 year | +41.6% | −22.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $43.5M | $225.4M |
| Dividend yield | — | — |
| Volatility (60d) | 54.8% | 76.3% |
| Short % of float | 21.5% | 39.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).